Race oncology should be at 30 cents in next couple months. Bisantrene has had mid 40 percent complete response rate in AML which is a booming area in blood cancer m&a. Will be easy for them to do a non dilutive deal with a partner. Hold and dont look back.
30 cent target
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
-0.015(0.99%) |
Mkt cap ! $258.9M | |||
| Open | High | Low | Value | Volume |
| $1.53 | $1.55 | $1.51 | $33.94K | 22.31K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 27696 | $1.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 34192 | 1 |
View Market Depth
| Last trade - 12.34pm 20/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |